Subscribe now to the Silphium Pharmaceutical Company newsletter.

Governance Policy

Governance Policy

Silphium Company for Pharmaceutical Industries and Preparations adopts a sound corporate governance policy to serve as a role model through:

  • An effective Board of Directors that includes independent members.
  • Specialized committees such as:

    • Internal Audit Committee.

    • Risk Committee.

    • Sharia Compliance Committee (Sharia Supervisory Board in coordination with an independent body).

  • Commitment to preparing periodic financial and operational reports for investors.

  • Disclosure of distributions, performance, and material risks.

  • Publishing annual reports including Sharia and accounting observations.

  • Appointing an independent external auditor.

  • Activating an effective internal audit system that reports to the audit committee.

  • Silphium Company adopts written policies that are submitted to the Board of Directors, covering:

    • Operational risks.

    • Market risks.

    • Sharia compliance risks.

  • Presence of an emergency response plan and periodic risk assessmen

  • An independent Sharia Supervisory Board exists.

  • All contracts and financing structures must be approved by the Board before implementation.

  • Issuing a periodic Sharia report on the compliance of the company’s activities with Sharia provisions.

  • Ensuring investors’ access to information.

  • Establishing mechanisms for dispute resolution (through the Commercial Arbitration Center).

  • Representation of sukuk holders through an agent or a follow-up committee.